High Performance Computing
Scientific discoveries with
Quantori’s hands-on experience
Unfold R&D faster and more productively with HPC
Boost your scientific discoveries and empower your decision-making with Quantori’s
Faster Discoveries with High Performance Find your Solution
Computing for Life Sciences
With flexible design, it could be integrated with the majority of tools used for computation in Genomics, CryoEM, computational chemistry, and other areas - depending on the customer’s focus.
- Interactive and batch processing
- Easier and quicker migration to the cloud
- Open-source components
- Unified environment
- Automated process
- High flexibility and customization
- Cloud agnostic
Molecular docking is one of the most frequently used methods in structure-based drug design. There are many different algorithms to perform docking and no unified way of running it.
With the Docking Factory accelerator, a user can analyze results from the run using RStudio/Jupyter without switching context, which saves a lot of time.
Real World Solutions in Action
“Third Rock Ventures (TRV) conceives, builds, and launches biotechnology companies that discover and develop products that make a difference for patients and their families. Each company has a core mission of improving lives...
“We approached Quantori to help us handle our big data problem of generating terabytes of CryoEM data every month. Our need was a computing infrastructure with expandable high speed storage capable of distilling our CryoEM datasets into high-resolution protein structures...
Quantori is the industry
leader in HPC
HPC Poster on Bio-IT 2022
• HPC is a breakthrough element for biotech and biopharma companies to unfold R&D faster and more productively • Researches can set high expectations and compute vast data rapidly to unlock insights and value
Quantori Announces Powerful HPC Accelerator to Advance Biopharma R&D
Quantori's HPC Accelerator brings the power of High Performance Computing to drug discovery and development, bridging the gap between science & IT.